161 related articles for article (PubMed ID: 11772847)
1. State and trait abnormalities in serotonin function in major depression.
Bhagwagar Z; Whale R; Cowen PJ
Br J Psychiatry; 2002 Jan; 180():24-8. PubMed ID: 11772847
[TBL] [Abstract][Full Text] [Related]
2. 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D-fenfluramine.
Park SB; Williamson DJ; Cowen PJ
Psychol Med; 1996 Nov; 26(6):1191-6. PubMed ID: 8931165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses.
Nadeem HS; Attenburrow MJ; Cowen PJ
Neuropsychopharmacology; 2004 Sep; 29(9):1699-703. PubMed ID: 15127082
[TBL] [Abstract][Full Text] [Related]
4. Citalopram challenge in social anxiety disorder.
Shlik J; Maron E; Tru I; Aluoja A; Vasar V
Int J Neuropsychopharmacol; 2004 Jun; 7(2):177-82. PubMed ID: 14741063
[TBL] [Abstract][Full Text] [Related]
5. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
Lykouras L; Markianos M; Hatzimanolis Y
Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
[TBL] [Abstract][Full Text] [Related]
6. Low-dose citalopram as a 5-HT neuroendocrine probe.
Attenburrow MJ; Mitter PR; Whale R; Terao T; Cowen PJ
Psychopharmacology (Berl); 2001 May; 155(3):323-6. PubMed ID: 11432696
[TBL] [Abstract][Full Text] [Related]
7. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
[TBL] [Abstract][Full Text] [Related]
8. The citalopram challenge test in patients with major depression and in healthy controls.
Kapitany T; Schindl M; Schindler SD; Hesselmann B; Füreder T; Barnas C; Sieghart W; Kasper S
Psychiatry Res; 1999 Nov; 88(2):75-88. PubMed ID: 10622344
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
Meltzer H; Bastani B; Jayathilake K; Maes M
Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
[TBL] [Abstract][Full Text] [Related]
10. The effects of an acute serotonergic challenge on brain-gut responses in irritable bowel syndrome patients and controls.
Kilkens TO; Honig A; Fekkes D; Brummer RJ
Aliment Pharmacol Ther; 2005 Nov; 22(9):865-74. PubMed ID: 16225497
[TBL] [Abstract][Full Text] [Related]
11. Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation.
Garcia-Leal C; Del-Ben CM; Leal FM; Graeff FG; Guimarães FS
J Psychopharmacol; 2010 May; 24(5):683-94. PubMed ID: 19251828
[TBL] [Abstract][Full Text] [Related]
12. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.
Gómez-Gil E; Navinés R; Martínez De Osaba MJ; Díaz-Ricart M; Escolar G; Salamero M; Martín-Santos R; Galán A; Gastó C
Psychoneuroendocrinology; 2010 May; 35(4):481-9. PubMed ID: 19762159
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
O'Keane V; Dinan TG
Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
[TBL] [Abstract][Full Text] [Related]
14. Specific effects of escitalopram on neuroendocrine response.
Hawken ER; Owen JA; Hudson RW; Delva NJ
Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine response to intravenous citalopram in healthy control subjects: pharmacokinetic influences.
Lotrich FE; Bies R; Muldoon MF; Manuck SB; Smith GS; Pollock BG
Psychopharmacology (Berl); 2005 Mar; 178(2-3):268-75. PubMed ID: 15365685
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia.
Brewerton TD; Mueller EA; Lesem MD; Brandt HA; Quearry B; George DT; Murphy DL; Jimerson DC
Arch Gen Psychiatry; 1992 Nov; 49(11):852-61. PubMed ID: 1444722
[TBL] [Abstract][Full Text] [Related]
17. Effect of valine on 5-HT-mediated prolactin release in healthy volunteers, and on mood in remitted depressed patients.
Williamson DJ; McTavish SF; Park SB; Cowen PJ
Br J Psychiatry; 1995 Aug; 167(2):238-42. PubMed ID: 7582676
[TBL] [Abstract][Full Text] [Related]
18. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025
[TBL] [Abstract][Full Text] [Related]
19. Impact of the selective serotonin reuptake inhibitor citalopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age.
Kauffman RP; Castracane VD; White DL; Baldock SD; Owens R
Gynecol Endocrinol; 2005 Sep; 21(3):129-37. PubMed ID: 16335904
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
